Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/3/14  and contains information from public web pages.

Peter K. Working

Wrong Peter K. Working?

Senior Vice President, Research a...

Phone: (650) ***-****  HQ Phone
Cell Genesys Inc
500 Forbes Boulevard
South San Francisco, California 94080
United States

Company Description: Cell Genesys, Inc. (Cell Genesys) is a biotechnology company focused on the development and commercialization of biological therapies for patients with cancer. The...   more
Background

Employment History

Education

  • Ph.D.
  • B.S. degrees
    University of California , Davis
11 Total References
Web References
Cell Genesys Fact Sheet - Strategic Growth
www.imagesrising.com, 3 Mar 2014 [cached]
Peter K. Working, Ph.D. Senior Vice President, Research and Development
Cell Genesys, Inc. 500 Forbes Boulevard South San Francisco, CA 94080 650.266.3000 Fax: 650.266.3010
Cell Genesys Appoints Peter Working Vice President of Research and Development
www.cellgenesys.com, 29 Aug 2001 [cached]
FOSTER CITY, Calif., August 29, 2001--Cell Genesys, Inc. (Nasdaq: CEGE) today announced that Peter K. Working, Ph.D., has joined the company in the new position of vice president, research and development.Dr. Working, who served most recently as vice president of analytical and non-clinical sciences and principal scientist at ALZA Corporation, brings over 20 years of pharmaceutical research and development experience to Cell Genesys including 13 years in the biotechnology industry.Dr. Working, who will report to Joe Vallner, Ph.D., president and chief operating officer, was, in the past, a key member of Dr. Vallner's team at SEQUUS Pharmaceuticals--a team which successfully developed and launched pharmaceutical products including the cancer product, Doxil®.
...
"We are delighted to have Peter join our executive team and believe that Peter's extensive experience in biopharmaceutical product development will prove to be invaluable as we continue to advance multiple product programs into Phase III clinical trials over the next eighteen months," stated Stephen A. Sherwin, M.D., chairman and chief executive officer of Cell Genesys.
...
Dr. Working, 53, previously with ALZA Corporation, has also held various positions with SEQUUS Pharmaceuticals, where he served as vice president of research and development, as well as Genentech, Inc. where he served as a senior toxicologist and head of the Experimental Toxicology Group in the Department of Safety Evaluation.Dr. Working holds Ph.D., M.S. and B.S. degrees from the University of California, Davis and the University of California, San Francisco.
Cell Genesys is focused on the development and commercialization of cancer vaccines and gene therapies to treat major, life-threatening diseases.The company is conducting clinical trials of GVAX® cancer vaccines in prostate cancer, lung cancer, pancreatic cancer and myeloma and expects to initiate new studies in acute leukemia during 2001.Preclinical stage programs include gene therapies for cancer, hemophilia and cardiovascular disorders.Cell Genesys' majority-owned subsidiary, Ceregene, is focused on gene therapies for central nervous system disorders.Cell Genesys also continues to hold a 10.5 percent equity interest in its former subsidiary, Abgenix, an antibody product company.Additionally, on August 2, 2001, Cell Genesys announced that it entered into a definitive agreement, expected to close in 30 days, for the acquisition of Calydon, Inc., a private biotechnology company focused on developing therapeutic products for cancer.
Peter Working - Cell Genesys Executive Committee - Management
www.gvax.com, 31 Jan 2009 [cached]
Peter K. Working, Ph.D. Senior Vice President, Research and Development
Peter K. Working, Ph.D., joined Cell Genesys in August 2001 and serves as senior vice president, research and development. Prior to joining Cell Genesys, Dr. Working was vice president of analytical and non clinical sciences and principal scientist at ALZA Corporation. Dr. Working has also held various positions with SEQUUS Pharmaceuticals, where he was vice president of research and development, as well as Genentech, Inc. where he served as a senior toxicologist and head of the Experimental Toxicology Group in the Department of Safety Evaluation. Dr. Working holds Ph.D., M.S. and B.S. degrees from the University of California, Davis and the University of California, San Francisco. He brought over 20 years of pharmaceutical research and development experience to Cell Genesys, including 13 years in the biotechnology industry.
Cell Genesys Management
www.imagesrising.com, 3 Mar 2014 [cached]
Peter K. Working, Ph.D. Senior Vice President, Research and Development
...
www.sec.gov, 1 Aug 2008 [cached]
0001207267 WORKING PETER K C/O CELL GENESYS, INC. 500 FORBES BOULEVARD SO SAN FRANCISCO CA 94080 0 1 0 0 SVP R&D
Other People with the name "Working":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304